F.D.A. Panel to Reassess Hormone Therapy Warnings NYT Par :Roni Caryn Rabin 17 juillet 2025 à 11:03 Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been overstated. © Al Drago for The New York TimesMarty Makary, commissioner of the Food and Drug Administration, in Washington earlier this year. Dr. Makary will convene a panel on Thursday to address menopause treatments.
Connexion
